MAP is thrilled to report that Patient Access Europe 2018 took place on Tuesday 30 October and was a resounding success. Delegates enjoyed talks in key market access topic areas:
- HTA developments
An international and expert group of speakers told us about new NICE and SMC ways of working and recapped some recent developments; we heard about how patient access works abroad in challenging situations, and we took some significant learnings about the AMNOG process in Germany.
Attendees networked and took part in panel sessions with a range of discussion topics, and MAP was delighted to see representatives from industry, HTA bodies, regulatory bodies and others all sharing their experiences and knowledge. It was exciting to witness a whole sector come together around a shared goal of improving patient access to the medicines they need.
Notes, insights and slides from the day will be available to attendees and our members in the coming weeks.
We thank all our speakers, delegates, and the hardworking MAP team for making the event a success, and we look forward to doing it all again next year.